£490.00

It has never been this cheap. We have no record of a lower price.

£490 today · cheaper than every other day in the last 3 months

Basal Cell Carcinoma Treatment Outlook 2023-2028 Report

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 18 days · 18 data points (no recent data)

Historical
Generating forecast…
£490.00 £465.50 £475.30 £485.10 £494.90 £504.70 £514.50 03 August 2026 07 August 2026 11 August 2026 15 August 2026 20 August 2026
View at Amazon ↗

Price data last checked 73 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 18 days • 1 price levels

Days at Price
18 days 0 5 9 14 18 £490 Days at Price

Price Analysis

Most common price: £490 (18 days, 100.0%)

Price range: £490 - £490

Price levels: 1 different prices over 18 days

Description

Gain actionable market intelligence with this comprehensive study on the latent demand for basal cell carcinoma treatments across the United States. Covering the period from 2023 to 2028, this report provides detailed potential industry earnings (P.I.E.) estimates for 10,833 US zip codes. By analyzing demand in millions of U.S. dollars, this data helps professionals identify significant market opportunities at a highly granular level. Each zip code entry includes a comparative benchmark showing its percent share relative to both its specific state and the United States as a whole. This statistical approach allows for rapid assessment of local market strength versus national trends. This report serves as a practical tool for refining distribution networks and optimizing sales force strategies based on localized demand projections.

Key Features

Provides latent demand outlooks for basal cell carcinoma treatments through 2028.

Includes potential industry earnings (P.I.E.) estimates across 10,833 US zip codes.

Reports percent share for each zip code relative to its state and the entire United States.

Offers comparative benchmarks to gauge individual zip code demand against others.

Supports sales force and distribution strategies through granular statistical data.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
09 January 2023
Listed Since
26 January 2023

Similar Products You Might Like

Basal Cell Carcinoma Surgery Outlook 2023-2028 US Report
99% match

Basal Cell Carcinoma Surgery Outlook 2023-2028 US Report

£490.00 21 Aug 2026
The 2023-2028 Outlook for Basal Cell Carcinoma Surgeries in China
99% match

The 2023-2028 Outlook for Basal Cell Carcinoma Surgeries in China

£495.00 26 Aug 2026
The 2023-2028 Outlook for Basal Cell Carcinoma Treatments in India
98% match

The 2023-2028 Outlook for Basal Cell Carcinoma Treatments in India

£515.00 12 Sep 2026
The 2025-2030 World Outlook for Basal Cell Carcinoma Surgeries
98% match

The 2025-2030 World Outlook for Basal Cell Carcinoma Surgeries

Price unavailable
US Cancer Screening Outlook 2023-2028 - Zip Code Study
97% match

US Cancer Screening Outlook 2023-2028 - Zip Code Study

£490.00 24 Aug 2026
The 2023-2028 Outlook for Cancer Testing-Screening for US Zip Codes
97% match

The 2023-2028 Outlook for Cancer Testing-Screening for US Zip Codes

£490.00 01 Oct 2026
US Cancer Diagnostics Lab Test Outlook 2023-2028 Study
97% match

US Cancer Diagnostics Lab Test Outlook 2023-2028 Study

£490.00 24 Aug 2026
Head and Neck Cancer Outlook 2023-2028 - US Zip Code Study
97% match

Head and Neck Cancer Outlook 2023-2028 - US Zip Code Study

£490.00 26 Aug 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics for US Zip Codes
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics for US Zip Codes

£490.00 02 Oct 2026
Breast Cancer Diagnostic Products Outlook 2023-2028 Report
97% match

Breast Cancer Diagnostic Products Outlook 2023-2028 Report

£490.00 20 Aug 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing for US Zip Codes
97% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing for US Zip Codes

£490.00 03 Oct 2026
The 2023-2028 Outlook for Cancer Screenings in Japan
96% match

The 2023-2028 Outlook for Cancer Screenings in Japan

£495.00 20 Aug 2026
Squamous Cell Carcinoma Head and Neck Treatment Outlook
96% match

Squamous Cell Carcinoma Head and Neck Treatment Outlook

£490.00 03 Sep 2026
Uterine Cancer Therapeutics and Diagnostics Outlook 2023-2028
96% match

Uterine Cancer Therapeutics and Diagnostics Outlook 2023-2028

£490.00 21 Aug 2026
The 2023-2028 Outlook for Cancer Testing-Screening in Japan
96% match

The 2023-2028 Outlook for Cancer Testing-Screening in Japan

£495.00 02 Oct 2026
The 2023-2028 Outlook for Cancer Vaccines for US Zip Codes
96% match

The 2023-2028 Outlook for Cancer Vaccines for US Zip Codes

£490.00 02 Oct 2026
Non-Small Cell Lung Cancer Outlook 2023-2028 US Zip Codes
96% match

Non-Small Cell Lung Cancer Outlook 2023-2028 US Zip Codes

£490.00 26 Aug 2026
The 2023-2028 Outlook for Cancer Supportive Care in the United States
96% match

The 2023-2028 Outlook for Cancer Supportive Care in the United States

£520.00 22 Aug 2026
The 2025-2030 World Outlook for Cancer Screenings
96% match

The 2025-2030 World Outlook for Cancer Screenings

Price unavailable
The 2023-2028 Outlook for Cancer Screenings in the United States
96% match

The 2023-2028 Outlook for Cancer Screenings in the United States

£520.00 20 Aug 2026
The 2023-2028 Outlook for Cancer Testing-Screening in China
96% match

The 2023-2028 Outlook for Cancer Testing-Screening in China

£495.00 02 Oct 2026
Primary Brain Tumor Diagnosis and Treatment Outlook 2023-2028
96% match

Primary Brain Tumor Diagnosis and Treatment Outlook 2023-2028

£490.00 22 Aug 2026
The 2023-2028 Outlook for Cancer Testing-Screening in the United States
96% match

The 2023-2028 Outlook for Cancer Testing-Screening in the United States

£520.00 30 Sep 2026
The 2023-2028 Outlook for Cancer Testing-Screening in India
96% match

The 2023-2028 Outlook for Cancer Testing-Screening in India

£515.00 01 Oct 2026